Health Catalyst Stock Price, News & Analysis

Health Catalyst (Nasdaq: HCAT) has announced a definitive agreement to acquire Vitalware, a provider of revenue workflow optimization technology based in Yakima, Washington. Vitalware's solutions include a Best in KLAS chargemaster management tool and products for Revenue Integrity and Price Transparency. This acquisition aims to enhance Health Catalyst’s analytics capabilities on its DOS™ platform, integrating charge and revenue data with claims and cost data. The transaction will be funded through a mix of cash and stock and is expected to close in Q3 or Q4 of 2020.

Health Catalyst (Nasdaq: HCAT) announced participation in two upcoming virtual investor conferences. Dan Burton (CEO), Patrick Nelli (CFO), and Adam Brown (SVP, Investor Relations) will be featured. The first event is the Verity Research HCIT / Services Conference on August 12, 2020, at 4:00 p.m. EST, followed by the Canaccord Genuity 40th Annual Growth Conference on August 13, 2020, at 10:00 a.m. EST. Health Catalyst focuses on healthcare improvement through data and analytics, leveraging over 100 million patient records to support informed decision-making.

On July 28, 2020, Health Catalyst (Nasdaq: HCAT) announced its new Financial Impact Recovery applications aimed at helping healthcare systems recover financially from the effects of COVID-19. These tools enable hospitals to prioritize and monitor backlogs in elective surgeries and outpatient visits, while also streamlining revenue cycles. With rapid implementation timelines, the applications have already been adopted by 15 clients, including Banner Health, which emphasized their need for timely data analytics to enhance financial performance amid the pandemic.

Health Catalyst (Nasdaq: HCAT) has announced a definitive agreement to acquire healthfinch, a company that enhances EMR workflows through automation and analytics. This acquisition aims to strengthen Health Catalyst's Population Health portfolio, previously bolstered by the Able Health acquisition. The healthfinch technology will be integrated into Health Catalyst’s Data Operating System, providing actionable insights and improving patient care efficiency. The transaction is expected to close in Q3 2020 and will be funded through a mix of stock and cash.

Health Catalyst (Nasdaq: HCAT) announced its participation in the COVID-19 Evidence Accelerator, a public-private partnership aimed at enhancing the understanding of COVID-19 using real-world data. The company will contribute insights from its COVID-19 National Registry, which includes data from over 64,000 patients and 500,000 with COVID-related symptoms. These efforts are intended to improve treatment outcomes and inform regulatory decisions. Health Catalyst aims to leverage its data and analytics expertise to help healthcare organizations better diagnose and manage COVID-19.

Health Catalyst, a leader in data and analytics for healthcare, announced their participation in two upcoming investor conferences. CEO Dan Burton will present at the William Blair 40th Annual Growth Stock Conference on June 10, 2020, at 1:20 p.m. CST, while CFO Patrick Nelli will speak at the Goldman Sachs 41st Annual Global Healthcare Conference on June 11, 2020, at 11:20 a.m. EST. The company supports healthcare organizations in making data-informed decisions, leveraging insights from over 100 million patient records.

Health Catalyst (Nasdaq: HCAT) reported its Q1 2020 financial results, revealing a 28% increase in total revenue, reaching $45.1 million compared to $35.2 million in Q1 2019. Technology revenue grew by 23% to $24.7 million, and professional services revenue surged 36% to $20.4 million. Despite the revenue growth, the company faced a net loss of $17.5 million, a 27% increase from the previous year. Adjusted EBITDA improved by 11% year-over-year, indicating resilience amid the COVID-19 pandemic. Health Catalyst remains committed to supporting healthcare organizations during these challenging times.

Health Catalyst (HCAT) announced the appointment of Mark Templeton to its Board and the nominating and corporate governance committee, effective June 15, 2020. Templeton, former CEO of DigitalOcean, replaces Promod Haque after his term concludes at the annual stockholders meeting on June 12, 2020. Templeton brings over 20 years of experience, including 14 years as Citrix's CEO, where he significantly expanded the company. Dan Burton, CEO of Health Catalyst, expressed confidence in Templeton's capabilities to drive growth and support the company's mission to improve healthcare through data-informed decisions.